Erythropoiesis Stimulating Agents (ESA)
J15 · Effective Oct 1, 2015
22 active Medicare policies list D07.30, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
J15
J9 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
3 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D07.30 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of D07.30 |
|---|---|---|
| Concert Genetic Testing: Toxicology and Pharmacogenetics Version B | Not recorded | Referenced |
| Policy | Effective | Status of D07.30 |
|---|---|---|
| Carcinoembryonic Antigen Testing | Oct 1, 2026 |
J8 · Effective Jul 3, 2022
J9 · Effective Oct 1, 2015
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
National · Effective Sep 27, 2026
National · Effective Oct 3, 2018
National · Effective May 7, 2026
National · Effective Aug 6, 2026
National · Effective Aug 13, 2026
J5 · Effective Aug 6, 2026
National · Effective Oct 30, 2025
National · Effective Jul 1, 2026
National · Effective Oct 1, 2026
| Covered |